speb/financial-data huggingface dataset:
Financial ratios for 9508.T — annual report dated 2023-03-31
Total revenue: 16676426426.426428
Gross profit: -548033033.0330331
Operating income: -548033033.0330331
Net income: -409054054.0540541
Capital expenditures: 0
Operating cash flow: 229009009.00900903
Depreciation & amortization: 1659249249.2492495
Net tangible assets: 4369842342.342342
Owner earnings: 1250195195.1951954
Buffett classification: The Gruesome
Stock price: 5.236411411411412
Shares outstanding: 472778133
Book value: 4633851351.351349
P/B ratio: 0.5342555518068176
Market cap (USD): 2475660810.706982
Debt to equity: 5.765092048494161
Current ratio: 0.7590996096864013
Quick ratio: 0.6186712777286937
Interest coverage ratio: -2.613044100801833
COGS to revenue (%): 103.28627380362852
Free cash flow (dilution-adjusted): 229009009.00900903
Buyback yield (%): 0.002122768689687541
Retained earnings: 1574579579.5795798
Inventory turnover: 14.391531802785094
Receivables turnover: 11.307836020342192
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.6336361013929483
FCF margin (%): 1.3732498987079638
Revenue growth (%): 16.723859771994107
Rule of 40 score: 18.09710967070207
Financial ratios for 9508.T — annual report dated 2024-03-31
Total revenue: 14127350765.979927
Gross profit: 1683306920.2324352
Operating income: 1683306920.2324352
Net income: 1111205758.0559957
Capital expenditures: 0
Operating cash flow: 3870073956.6825147
Depreciation & amortization: 1650561278.3940835
Net tangible assets: 5880401479.133651
Owner earnings: 2761767036.450079
Return on net tangible assets (%): 46.96562039598979
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.530969360802958
P/E ratio: 3.629621011086754
Shares outstanding: 472778133
Book value: 6081887216.059166
P/B ratio: 0.6631585926866338
Market cap (USD): 4033255767.080626
Debt to equity: 3.6345906425446857
Current ratio: 0.8292670721310832
Quick ratio: 0.7130806061591749
Effective tax rate (%): 25.195033805859683
Interest coverage ratio: 9.087085160232418
COGS to revenue (%): 88.08476586929514
Free cash flow (dilution-adjusted): 3870073956.6825147
Buyback yield (%): 16.835728679276144
Retained earnings: 2626796090.8610673
Inventory turnover: 14.494346936578014
Receivables turnover: 11.728068588594516
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.531885159348759
FCF margin (%): 27.3941945718658
Revenue growth (%): -15.285502992458195
Rule of 40 score: 12.108691579407605
Financial ratios for 9508.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 6743080263.342205
Buffett classification: The Gruesome
Stock price: 10.42646028855582
Shares outstanding: 472778133
Book value: 6955953214.735958
P/B ratio: 0.7086595146412551
Market cap (USD): 4929402429.022061
Debt to equity: 3.4534214148419555
Current ratio: 0.8749287559063651
Quick ratio: 0.7538965318036537
Buyback yield (%): 0
Retained earnings: 3196344025.7739177
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9508.T — annual report dated 2025-03-31
Total revenue: 15752118700.708462
Gross profit: 1333812324.5555406
Operating income: 1333812324.5555406
Net income: 872309851.6241144
Capital expenditures: 0
Operating cash flow: 2886512498.3291
Depreciation & amortization: 1675210533.3511562
Net tangible assets: 6680042775.030076
Owner earnings: 2547520384.9752707
Return on net tangible assets (%): 38.13628850548492
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.466448335783985
P/E ratio: 4.588680994351224
Shares outstanding: 472778133
Book value: 6892648041.705658
P/B ratio: 0.580727699008172
Market cap (USD): 4002751637.3329096
Debt to equity: 3.260957763086188
Current ratio: 0.8433547442563498
Quick ratio: 0.7598176858508164
Effective tax rate (%): 27.711590759295262
Interest coverage ratio: 6.646185100076598
COGS to revenue (%): 91.53248937556855
Free cash flow (dilution-adjusted): 2886512498.3291
Buyback yield (%): 0
Retained earnings: 3315779975.9390454
Inventory turnover: 24.050335570469798
Receivables turnover: 9.033953527594429
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.245816307730144
FCF margin (%): 18.32459844401298
Revenue growth (%): 11.500867796396323
Rule of 40 score: 29.825466240409305
Financial ratios for 9508.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 6680042775.030076
Buffett classification: The Gruesome
Stock price: 8.466448335783985
Shares outstanding: 472778133
Book value: 6892648041.705658
P/B ratio: 0.580727699008172
Market cap (USD): 4002751637.3329096
Debt to equity: 3.260957763086188
Current ratio: 0.8433547442563498
Quick ratio: 0.7598176858508164
Buyback yield (%): 0
Retained earnings: 3315779975.9390454
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9508.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.644409078328259
Shares outstanding: 472778133
Market cap (USD): 4086887584.940285
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9508.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 7378438761.776582
Buffett classification: The Gruesome
Stock price: 9.821265141318978
Shares outstanding: 472778133
Book value: 7592368775.235531
P/B ratio: 0.6115718999788341
Market cap (USD): 4643279397.210768
Debt to equity: 2.9098965987311054
Current ratio: 0.8647041869090076
Quick ratio: 0.7646734544343314
Buyback yield (%): 0
Retained earnings: 4068492597.5773892
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AB.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.636363636363637
Shares outstanding: 73251991
Market cap (USD): 998890786.3636364
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AB.PA — annual report dated 2022-12-31
Total revenue: 1019148.9361702128
Gross profit: 986170.2127659575
Operating income: -16955319.14893617
Net income: -14484042.55319149
Capital expenditures: 685106.3829787235
Operating cash flow: -18586170.21276596
Depreciation & amortization: -86170.21276595745
Net tangible assets: -39676595.74468085
Owner earnings: -15255319.148936173
Buffett classification: The Gruesome
Stock price: 7.542553191489362
Shares outstanding: 73251991
Book value: -37946808.5106383
Market cap (USD): 552507038.5
Debt to equity: -0.6716288197364733
Current ratio: 0.9043719398587462
Quick ratio: 0.8846137180987046
Interest coverage ratio: -7.905753968253968
COGS to revenue (%): 3.235908141962422
R&D to revenue (%): 1393.0062630480168
SG&A to revenue (%): 224.94780793319413
Free cash flow (dilution-adjusted): -19412765.95744681
Buyback yield (%): 0
Inventory turnover: 0.06798245614035088
Receivables turnover: 5.9875
Capitalized R&D asset: 14196808.510638298
ROCI (R&D-adjusted, %): -49.91375440088844
FCF margin (%): -1904.801670146138
Rule of 40 score: -1904.801670146138
Financial ratios for AB.PA — annual report dated 2023-12-31
Total revenue: 1077777.7777777778
Gross profit: 652222.2222222222
Operating income: -14921111.11111111
Net income: -13316666.666666666
Capital expenditures: 383333.3333333333
Operating cash flow: -18745555.555555556
Depreciation & amortization: 2523333.3333333335
Net tangible assets: -24903333.333333332
Owner earnings: -11176666.666666666
Buffett classification: The Gruesome
Stock price: 3.9555555555555557
Shares outstanding: 73251991
Book value: -23344444.444444444
Market cap (USD): 289752319.95555556
Debt to equity: -0.909138505473584
Current ratio: 1.0378418883476959
Quick ratio: 1.0198576245784938
Interest coverage ratio: -5.305807981035164
COGS to revenue (%): 39.48453608247423
R&D to revenue (%): 1080.103092783505
SG&A to revenue (%): 189.69072164948454
Free cash flow (dilution-adjusted): -19801111.111111112
Buyback yield (%): 0
Inventory turnover: 1.1398809523809526
Receivables turnover: 4.110169491525424
Capitalized R&D asset: 21152972.81323877
ROCI (R&D-adjusted, %): -41.39982291226682
Rosenberg metric: -0.02352275092627284
FCF margin (%): -1837.2164948453608
Revenue growth (%): 5.752725585710965
Rule of 40 score: -1831.4637692596498
Financial ratios for AB.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -26125000
Buffett classification: The Gruesome
Stock price: 0.9166666666666667
Shares outstanding: 73251991
Book value: -24743750
Market cap (USD): 67147658.41666667
Debt to equity: -0.7776795487075862
Current ratio: 0.7108109430822689
Quick ratio: 0.701805902217002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AB.PA — annual report dated 2024-12-31
Total revenue: 1116666.6666666667
Gross profit: 1300000
Operating income: -6336458.333333334
Net income: -8157291.666666667
Capital expenditures: 141666.6666666667
Operating cash flow: 546875
Depreciation & amortization: 694791.6666666667
Net tangible assets: -26125000
Owner earnings: -7604166.666666667
Buffett classification: The Gruesome
Stock price: 0.9166666666666667
Shares outstanding: 73251991
Book value: -24743750
Market cap (USD): 67147658.41666667
Debt to equity: -0.7776795487075862
Current ratio: 0.7108109430822689
Quick ratio: 0.701805902217002
Interest coverage ratio: -2.7059608540925266
COGS to revenue (%): -16.417910447761194
R&D to revenue (%): 367.1641791044776
SG&A to revenue (%): 179.6641791044776
Free cash flow (dilution-adjusted): -673958.3333333333
Buyback yield (%): 0
Inventory turnover: -0.9565217391304347
Receivables turnover: 8.246153846153845
Capitalized R&D asset: 16584491.252955083
ROCI (R&D-adjusted, %): -62.835900725028246
Rosenberg metric: 0.05564570010499189
FCF margin (%): -60.35447761194028
Revenue growth (%): 3.6082474226804218
Rule of 40 score: -56.74623018925986
Financial ratios for ALLOG.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.3977272727272727
Shares outstanding: 11002778
Market cap (USD): 4376104.886363636
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALLOG.PA — annual report dated 2022-12-31
Total revenue: 10548960.638297873
Gross profit: 1769807.4468085107
Operating income: -195554.25531914894
Net income: 25301.063829787236
Capital expenditures: 5093.6170212765965
Operating cash flow: -865859.5744680852
Depreciation & amortization: 63751.063829787236
Net tangible assets: 4828334.042553192
Owner earnings: 83958.51063829787
Return on net tangible assets (%): 1.7388712110295739
Buffett classification: The Gruesome
Stock price: 0.3191489361702128
P/E ratio: 138.78961443047555
Shares outstanding: 11002778
Book value: 4828334.042553192
P/B ratio: 0.7272746381400218
Market cap (USD): 3511524.8936170214
Debt to equity: 0.25710709433719486
Current ratio: 4.3318119091215825
Quick ratio: 3.0680945441172356
Effective tax rate (%): -85.19816242310986
Interest coverage ratio: -13.575142160844841
COGS to revenue (%): 83.22292112472914
Free cash flow (dilution-adjusted): -877308.5106382979
Buyback yield (%): 0
Retained earnings: 25301.063829787236
Inventory turnover: 3.8860353031754964
Receivables turnover: 14.936288952353408
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.1796977867818557
FCF margin (%): -8.316539806331631
Rule of 40 score: -8.316539806331631
Financial ratios for ALLOG.PA — annual report dated 2023-12-31
Total revenue: 18142696.666666668
Gross profit: 3152020
Operating income: 825644.4444444444
Net income: 701147.7777777778
Capital expenditures: 63142.22222222222
Operating cash flow: -568687.7777777778
Depreciation & amortization: 403998.8888888889
Net tangible assets: 3816178.888888889
Owner earnings: 1042004.4444444443
Return on net tangible assets (%): 27.304916115916996
Capex to operating income (%): 7.647628788286591
Buffett classification: The Great
Stock price: 0.6444444444444444
P/E ratio: 10.112959607500716
Shares outstanding: 11002778
Book value: 5744072.222222224
P/B ratio: 1.2344341925443907
Market cap (USD): 7090679.155555555
Debt to equity: 0.9625173004440324
Current ratio: 2.7585639711495773
Quick ratio: 2.178904086397946
Effective tax rate (%): 7.858328721638073
Interest coverage ratio: 15.161494358409335
COGS to revenue (%): 82.62650774627586
Free cash flow (dilution-adjusted): -631830
Buyback yield (%): 0
Retained earnings: 701147.7777777778
Inventory turnover: 4.646637306911161
Receivables turnover: 2.9370056815759695
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.911664852898772
FCF margin (%): -3.4825583627865684
Revenue growth (%): 71.9856324119727
Rule of 40 score: 68.50307404918614
Financial ratios for ALLOG.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 4553553.125
Buffett classification: The Gruesome
Stock price: 0.9375000000000001
Shares outstanding: 11002778
Book value: 6669104.166666666
P/B ratio: 1.5467001440098467
Market cap (USD): 10315104.375000002
Debt to equity: 0.594076384571891
Current ratio: 1.5478731419594896
Quick ratio: 1.2500026973584435
Buyback yield (%): 0
Retained earnings: 1284039.5833333335
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALLOG.PA — annual report dated 2024-12-31
Total revenue: 28530795.833333336
Gross profit: 4893440.625
Operating income: 1820070.8333333335
Net income: 1284039.5833333335
Capital expenditures: 958.3333333333334
Operating cash flow: 2168028.125
Depreciation & amortization: 161104.1666666667
Net tangible assets: 4553553.125
Owner earnings: 1444185.416666667
Return on net tangible assets (%): 31.715571928606124
Capex to operating income (%): 0.05265362840731931
Buffett classification: The Great
Stock price: 0.9375000000000001
P/E ratio: 8.033322733106294
Shares outstanding: 11002778
Book value: 6669104.166666666
P/B ratio: 1.5467001440098467
Market cap (USD): 10315104.375000002
Debt to equity: 0.594076384571891
Current ratio: 1.5478731419594896
Quick ratio: 1.2500026973584435
Effective tax rate (%): 23.858571308563157
Interest coverage ratio: 8.453445448080004
COGS to revenue (%): 82.84856597206146
Free cash flow (dilution-adjusted): 2167069.791666667
Buyback yield (%): 0
Retained earnings: 1284039.5833333335
Inventory turnover: 9.235307237013737
Receivables turnover: 6.159355566884493
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.960687848249997
FCF margin (%): 7.595546245277947
Revenue growth (%): 57.257745954340855
Rule of 40 score: 64.8532921996188
Financial ratios for AVA.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.16541353383458646
Shares outstanding: 291099082
Market cap (USD): 48151727.84962406
Buyback yield (%): 0.029668123915154207
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AVA.AX — annual report dated 2022-06-30
Total revenue: 12842068.965517242
Gross profit: 8270344.827586208
Operating income: -866206.8965517242
Net income: 22849655.172413792
Capital expenditures: 186206.89655172414
Depreciation & amortization: 1164827.5862068967
Net tangible assets: 13788965.51724138
Owner earnings: 23828275.862068966
Return on net tangible assets (%): 172.8068420526158
Buffett classification: The Gruesome
Stock price: 0.12413793103448276
P/E ratio: 1.5814872256428831
Shares outstanding: 291099082
Book value: 18171034.482758623
P/B ratio: 1.9886835721876421
Market cap (USD): 36136437.76551724
Debt to equity: 0.010778806740549566
Current ratio: 6.01879228263593
Quick ratio: 5.202956652468053
Interest coverage ratio: -46.51851851851852
COGS to revenue (%): 35.599591858654215
R&D to revenue (%): 9.446324042747435
SG&A to revenue (%): 38.649911390365716
Free cash flow (dilution-adjusted): 751034.4827586208
Buyback yield (%): 16.99879401657932
Retained earnings: -15561379.310344828
Inventory turnover: 2.035933660933661
Receivables turnover: 3.9103317933641324
Capitalized R&D asset: 1213103.448275862
ROCI (R&D-adjusted, %): -0.29158939547686563
FCF margin (%): 5.8482358627356215
Rule of 40 score: 5.8482358627356215
Financial ratios for AVA.AX — annual report dated 2023-06-30
Total revenue: 18941059.602649007
Gross profit: 12058278.145695364
Operating income: -556291.3907284768
Net income: -698013.2450331126
Capital expenditures: 303973.5099337748
Depreciation & amortization: 1368874.1721854305
Net tangible assets: 10377483.44370861
Owner earnings: 366887.4172185431
Buffett classification: The Gruesome
Stock price: 0.13245033112582782
Shares outstanding: 291099082
Book value: 19373509.933774836
P/B ratio: 1.9901489163875024
Market cap (USD): 38556169.80132451
Debt to equity: 0.09673890749982908
Current ratio: 3.3765895510954493
Quick ratio: 2.233032020836525
Interest coverage ratio: -4.3076923076923075
COGS to revenue (%): 36.33789028355652
R&D to revenue (%): 6.178105660641236
SG&A to revenue (%): 41.264291458340615
Free cash flow (dilution-adjusted): -3047682.119205298
Buyback yield (%): 0.0051528846800004665
Retained earnings: -15641059.602649007
Inventory turnover: 1.392416934619507
Receivables turnover: 3.4097520267048163
Capitalized R&D asset: 1982977.9858415164
ROCI (R&D-adjusted, %): -0.8126915227675662
Rosenberg metric: 3.122514673825058
FCF margin (%): -16.090346491381418
Revenue growth (%): 47.49227444197981
Rule of 40 score: 31.40192795059839
Financial ratios for AVA.AX — annual report dated 2024-06-30
Total revenue: 20096666.666666668
Gross profit: 11997333.333333334
Operating income: -2257333.3333333335
Net income: -3468666.6666666665
Capital expenditures: 236666.66666666666
Depreciation & amortization: 1634000
Net tangible assets: 10100666.666666666
Owner earnings: -2071333.3333333333
Return on net tangible assets (%): -20.506897234505974
Buffett classification: The Gruesome
Stock price: 0.06666666666666667
Shares outstanding: 291099082
Book value: 18632666.666666668
P/B ratio: 1.041536663207986
Market cap (USD): 19406605.466666665
Debt to equity: 0.1080897348742352
Current ratio: 3.117921094773621
Quick ratio: 2.159411850342117
Interest coverage ratio: -14.108333333333334
COGS to revenue (%): 40.30187427434068
R&D to revenue (%): 6.637916735777077
SG&A to revenue (%): 43.758500580527446
Free cash flow (dilution-adjusted): -2175333.3333333335
Buyback yield (%): 0.8278968052534086
Retained earnings: -19504666.666666668
Inventory turnover: 1.8452308626974485
Receivables turnover: 3.345355676395517
Capitalized R&D asset: 2518357.250513816
ROCI (R&D-adjusted, %): -9.839521717802018
Rosenberg metric: -0.05208073948311574
FCF margin (%): -10.824348979930337
Revenue growth (%): 6.101068727200685
Rule of 40 score: -4.723280252729651
Financial ratios for CAQ.AX — annual report dated 2021-12-31
Total revenue: 330895.89743589744
Gross profit: 330895.89743589744
Operating income: -97645.89743589744
Net income: -162786.02564102566
Capital expenditures: 2104.3589743589746
Depreciation & amortization: 15595.25641025641
Net tangible assets: 8229138.58974359
Owner earnings: -149295.12820512822
Return on net tangible assets (%): -1.8142254693729745
Buffett classification: The Gruesome
Stock price: 0.014492753623188408
Shares outstanding: 717786281
Book value: 16742399.230769232
P/B ratio: 0.6213386493328609
Market cap (USD): 10402699.724637682
Debt to equity: 0.04986428054907487
Current ratio: 1.4359773270611542
Quick ratio: 0.5674891911667439
Interest coverage ratio: -203.15764203787677
COGS to revenue (%): 0
SG&A to revenue (%): 73.11537287271386
Free cash flow (dilution-adjusted): 12259.48717948718
Buyback yield (%): 0
Retained earnings: -2073887.0512820513
Inventory turnover: 0
Receivables turnover: 12.327636770058175
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.5476982704729911
FCF margin (%): 3.704937799013401
Rule of 40 score: 3.704937799013401
Financial ratios for CAQ.AX — annual report dated 2022-12-31
Total revenue: 478653.14505776635
Gross profit: 477123.7483953787
Operating income: -55901.79717586649
Net income: -68393.70988446726
Capital expenditures: 4111.93838254172
Depreciation & amortization: 8430.038510911425
Net tangible assets: 8029626.700898588
Owner earnings: -64075.60975609755
Return on net tangible assets (%): -0.797989895955274
Buffett classification: The Gruesome
Stock price: 0.02027027027027027
Shares outstanding: 717786281
Book value: 7693588.446726572
P/B ratio: 1.8911489759180846
Market cap (USD): 14549721.912162162
Debt to equity: 0.09764067754665064
Current ratio: 0.9274792518087693
Quick ratio: 0.14012203804019813
Interest coverage ratio: -5.001837749675522
COGS to revenue (%): 0.31952086352699116
SG&A to revenue (%): 49.272375310697434
Free cash flow (dilution-adjusted): 63820.795892169444
Buyback yield (%): 0
Retained earnings: -2144943.003851091
Inventory turnover: 0.004659453912314349
Receivables turnover: 10.97191922104749
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6389513049484551
FCF margin (%): 13.333412002227044
Revenue growth (%): 44.65369585021618
Rule of 40 score: 57.98710785244322
Financial ratios for CAQ.AX — annual report dated 2023-12-31
Total revenue: 335626.1203585147
Gross profit: 181283.61075544174
Operating income: -179569.01408450704
Net income: -401860.56338028173
Capital expenditures: 5167.86171574904
Depreciation & amortization: 4401.920614596671
Net tangible assets: 7392554.417413573
Owner earnings: -402626.50448143407
Return on net tangible assets (%): -5.446378636497081
Buffett classification: The Gruesome
Stock price: 0.006849315068493151
Shares outstanding: 717786281
Book value: 6859637.772087068
P/B ratio: 0.7167061226492641
Market cap (USD): 4916344.390410959
Debt to equity: 0.12239328831267077
Current ratio: 0.43494065709176016
Quick ratio: 0.3932226492320692
Interest coverage ratio: -9.752195651115732
COGS to revenue (%): 45.98644153148892
SG&A to revenue (%): 62.51083456684623
Free cash flow (dilution-adjusted): -48420.99871959027
Buyback yield (%): 0
Retained earnings: -2541310.7554417416
Inventory turnover: 6.963289238056728
Receivables turnover: 20.92823096391987
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.3082888257021663
FCF margin (%): -14.427065053180938
Revenue growth (%): -29.88114173615017
Rule of 40 score: -44.30820678933111
Financial ratios for CDRE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 24.1
Shares outstanding: 42797451
Market cap (USD): 1031418569.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CDRE — annual report dated 2022-12-31
Total revenue: 457837000
Gross profit: 175678000
Operating income: 21071000
Net income: 5820000
Capital expenditures: 4083000
Operating cash flow: 46409000
Depreciation & amortization: 15651000
Net tangible assets: 33619000
Owner earnings: 17388000
Return on net tangible assets (%): 51.720753145542695
Capex to operating income (%): 19.37734326799867
Buffett classification: The Great
Stock price: 19.34
P/E ratio: 142.21695916494843
Shares outstanding: 42797451
Book value: 165890000
P/B ratio: 4.989467130869854
Market cap (USD): 827702702.34
Debt to equity: 0.9550003014045452
Current ratio: 2.4963951293065216
Quick ratio: 1.6059730616692642
Effective tax rate (%): 37.90675344073403
Interest coverage ratio: 3.395262649049307
COGS to revenue (%): 61.628701917931494
SG&A to revenue (%): 33.44618281178673
Free cash flow (dilution-adjusted): 10057000
Buyback yield (%): 0
Retained earnings: -42741000
Inventory turnover: 4.015183640943179
Receivables turnover: 7.091980730207414
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.731282205276794
FCF margin (%): 2.1966332996241023
Rule of 40 score: 2.1966332996241023
Financial ratios for CDRE — annual report dated 2023-12-31
Total revenue: 482532000
Gross profit: 200726000
Operating income: 58711000
Net income: 38641000
Capital expenditures: 6520000
Operating cash flow: 73209000
Depreciation & amortization: 15737000
Net tangible assets: 72023000
Owner earnings: 47858000
Return on net tangible assets (%): 66.44821793038335
Capex to operating income (%): 11.105244332407896
Buffett classification: The Great
Stock price: 32.02
P/E ratio: 35.46425768018427
Shares outstanding: 42797451
Book value: 197162000
P/B ratio: 6.950499492904313
Market cap (USD): 1370374381.0200002
Debt to equity: 0.7447073979772979
Current ratio: 2.5822217087158372
Quick ratio: 1.7316870785454699
Effective tax rate (%): 26.98775602751115
Interest coverage ratio: 12.957625248289562
COGS to revenue (%): 58.40151533991528
SG&A to revenue (%): 29.121177455588438
Free cash flow (dilution-adjusted): 57114000
Buyback yield (%): 0
Retained earnings: -16106000
Inventory turnover: 3.4801175656984786
Receivables turnover: 8.268197395476353
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.47491613909451
FCF margin (%): 11.836313446569346
Revenue growth (%): 5.393841039496589
Rule of 40 score: 17.230154486065935
Financial ratios for CDRE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 37.23
Shares outstanding: 42797451
Market cap (USD): 1593349100.7299998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CDRE — annual report dated 2024-12-31
Total revenue: 567561000
Gross profit: 233481000
Operating income: 72768000
Net income: 36133000
Capital expenditures: 5613000
Operating cash flow: 31777000
Depreciation & amortization: 16420000
Net tangible assets: 55814000
Owner earnings: 46940000
Return on net tangible assets (%): 84.10076324936396
Capex to operating income (%): 7.713555408970977
Buffett classification: The Great
Stock price: 31.77
P/E ratio: 37.62972956217308
Shares outstanding: 42797451
Book value: 311515000
P/B ratio: 4.364717648492047
Market cap (USD): 1359675018.27
Debt to equity: 0.7664542638396225
Current ratio: 3.4801699867197877
Quick ratio: 2.6052589641434265
Effective tax rate (%): 33.35608100630787
Interest coverage ratio: 9.302991562260292
COGS to revenue (%): 58.862395407718296
SG&A to revenue (%): 27.895327550694994
Free cash flow (dilution-adjusted): 17740000
Buyback yield (%): 0
Retained earnings: 6079000
Inventory turnover: 4.056781338417263
Receivables turnover: 6.0686782930402146
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.027132698876454
FCF margin (%): 3.125655215915118
Revenue growth (%): 17.621421998955512
Rule of 40 score: 20.74707721487063
Financial ratios for CDRE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 31.77
Shares outstanding: 42797451
Market cap (USD): 1359675018.27
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CDRE — quarterly report dated 2025-03-31
Total revenue: 130106000
Gross profit: 56131000
Operating income: 14250000
Net income: 9248000
Capital expenditures: 1309000
Operating cash flow: 17391000
Depreciation & amortization: 3856000
Net tangible assets: 63067000
Owner earnings: 11795000
Return on net tangible assets (%): 18.70233244010338
Capex to operating income (%): 9.185964912280701
Buffett classification: The Great
Stock price: 29.19
P/E ratio: 33.771020617701126
Shares outstanding: 42797451
Book value: 317562000
P/B ratio: 3.933901394656792
Market cap (USD): 1249257594.69
Debt to equity: 0.7289820570471278
Current ratio: 3.5500074733627995
Quick ratio: 2.5700787905963742
Effective tax rate (%): 26.649746192893403
Interest coverage ratio: 6.387270282384581
COGS to revenue (%): 56.857485434953034
SG&A to revenue (%): 32.09152537162006
Free cash flow (dilution-adjusted): 14114000
Buyback yield (%): 0
Retained earnings: 11468000
Inventory turnover: 0.8059507985967359
Receivables turnover: 1.5693951895008564
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5327614920720123
FCF margin (%): 10.848077721242678
Rule of 40 score: 10.848077721242678
Financial ratios for CDRE — quarterly report dated 2025-06-30
Total revenue: 157109000
Gross profit: 64249000
Operating income: 18011000
Net income: 12211000
Capital expenditures: 1418000
Operating cash flow: 2588000
Depreciation & amortization: 4676000
Net tangible assets: 31587000
Owner earnings: 15469000
Return on net tangible assets (%): 48.9726786336151
Capex to operating income (%): 7.872966520459719
Buffett classification: The Great
Stock price: 31.5
P/E ratio: 62.82304424716902
Shares outstanding: 42797451
Book value: 332460000
P/B ratio: 4.054983175419599
Market cap (USD): 1348119706.5
Debt to equity: 0.9949918787222523
Current ratio: 3.5921861447373384
Quick ratio: 2.5588490402383375
Effective tax rate (%): 29.04294264628973
Interest coverage ratio: 5.016991643454039
COGS to revenue (%): 59.10546181313611
SG&A to revenue (%): 28.724643400441728
Free cash flow (dilution-adjusted): -1261000
Buyback yield (%): 0
Retained earnings: 19817000
Inventory turnover: 0.8472318528520857
Receivables turnover: 1.4530043374920232
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6164745942946297
FCF margin (%): -0.8026274751923823
Revenue growth (%): 20.75461546738813
Rule of 40 score: 19.95198799219575
Financial ratios for CDRE — quarterly report dated 2025-09-30
Total revenue: 155869000
Gross profit: 66625000
Operating income: 20890000
Net income: 10941000
Capital expenditures: 849000
Operating cash flow: 22476000
Depreciation & amortization: 5376000
Net tangible assets: 43296000
Owner earnings: 15468000
Return on net tangible assets (%): 35.72616407982262
Capex to operating income (%): 4.064145524174246
Buffett classification: The Great
Stock price: 36.22
P/E ratio: 47.843323309259254
Shares outstanding: 42797451
Book value: 340374000
P/B ratio: 4.554177684605757
Market cap (USD): 1550123675.22
Debt to equity: 0.9615011722399478
Current ratio: 3.6420353815397384
Quick ratio: 2.5839745765908493
Effective tax rate (%): 26.293451899757475
Interest coverage ratio: 6.898943196829591
COGS to revenue (%): 57.255772475604516
SG&A to revenue (%): 29.27265845036537
Free cash flow (dilution-adjusted): 19180000
Buyback yield (%): 0
Retained earnings: 26895000
Inventory turnover: 0.7953939804458071
Receivables turnover: 1.5676885321746827
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.045140675586835
FCF margin (%): 12.30520501190102
Revenue growth (%): -0.7892609589520652
Rule of 40 score: 11.515944052948955
Financial ratios for CDRE — quarterly report dated 2025-12-31
Total revenue: 167224000
Gross profit: 72623000
Operating income: 21896000
Net income: 11739000
Capital expenditures: 3203000
Operating cash flow: 21250000
Depreciation & amortization: 4725000
Net tangible assets: 21414000
Owner earnings: 13261000
Return on net tangible assets (%): 61.92677687494162
Capex to operating income (%): 14.628242601388381
Buffett classification: The Great
Stock price: 40.6
P/E ratio: 39.36601442261945
Shares outstanding: 42797451
Book value: 317804000
P/B ratio: 5.467446950321582
Market cap (USD): 1737576510.6000001
Debt to equity: 1.0315634793772261
Current ratio: 3.5012775730896215
Quick ratio: 2.5417771185224174
Effective tax rate (%): 33.54656099632041
Interest coverage ratio: 6.030294684659873
COGS to revenue (%): 56.57142515428407
SG&A to revenue (%): 30.270176529684733
Free cash flow (dilution-adjusted): 12577000
Buyback yield (%): 0
Retained earnings: 34770000
Inventory turnover: 0.9435285199924199
Receivables turnover: 1.511875378592675
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2899798057505527
FCF margin (%): 7.5210496101038125
Revenue growth (%): 7.284963655377272
Rule of 40 score: 14.806013265481084
Financial ratios for CDRE — annual report dated 2025-12-31
Total revenue: 610308000
Gross profit: 259628000
Operating income: 75047000
Net income: 44139000
Capital expenditures: 6779000
Operating cash flow: 63705000
Depreciation & amortization: 18633000
Net tangible assets: 21414000
Owner earnings: 55993000
Return on net tangible assets (%): 261.47847202764547
Capex to operating income (%): 9.033005982917372
Buffett classification: The Great
Stock price: 40.6
P/E ratio: 39.36601442261945
Shares outstanding: 42797451
Book value: 317804000
P/B ratio: 5.467446950321582
Market cap (USD): 1737576510.6000001
Debt to equity: 1.0315634793772261
Current ratio: 3.5012775730896215
Quick ratio: 2.5417771185224174
Effective tax rate (%): 29.180438340339503
Interest coverage ratio: 6.01338141025641
COGS to revenue (%): 57.459512246275644
SG&A to revenue (%): 30.00583312032613
Free cash flow (dilution-adjusted): 44610000
Buyback yield (%): 0
Retained earnings: 34770000
Inventory turnover: 3.497601308558491
Receivables turnover: 5.517806287124685
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.27617439176844
FCF margin (%): 7.3094240940639805
Revenue growth (%): 7.5317014382595
Rule of 40 score: 14.841125532323481
Financial ratios for CUZ — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 32
Shares outstanding: 164540333
Market cap (USD): 5265290656
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CUZ — annual report dated 2022-12-31
Total revenue: 762290000
Gross profit: 503919000
Operating income: 180013000
Net income: 167445000
Capital expenditures: 342241000
Operating cash flow: 365166000
Depreciation & amortization: 295587000
Net tangible assets: 4489424000
Owner earnings: 120791000
Return on net tangible assets (%): 2.6905678768590358
Capex to operating income (%): 190.1201579885897
Buffett classification: The Gruesome
Stock price: 20.91
P/E ratio: 20.547274406700705
Shares outstanding: 164540333
Book value: 4646949000
P/B ratio: 0.7403865123180822
Market cap (USD): 3440538363.03
Debt to equity: 0.5138285356693176
Current ratio: 0.4570089442462994
Quick ratio: 0.4570089442462994
Interest coverage ratio: 2.4816714228600576
COGS to revenue (%): 33.89405606790067
SG&A to revenue (%): 3.7149903580002364
Free cash flow (dilution-adjusted): 12787000
Buyback yield (%): 0
Retained earnings: -1013292000
Receivables turnover: 3.955920205920206
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.53392682998241
FCF margin (%): 1.6774455915727609
Rule of 40 score: 1.6774455915727609
Financial ratios for CUZ — annual report dated 2023-12-31
Total revenue: 802874000
Gross profit: 536440000
Operating income: 189212000
Net income: 83816000
Capital expenditures: 279519000
Operating cash flow: 368362000
Depreciation & amortization: 314897000
Net tangible assets: 4413484000
Owner earnings: 119194000
Return on net tangible assets (%): 2.7006781943697997
Capex to operating income (%): 147.72794537344353
Buffett classification: The Gruesome
Stock price: 21.33
P/E ratio: 41.87321397931183
Shares outstanding: 164540333
Book value: 4548313000
P/B ratio: 0.7716367151710974
Market cap (USD): 3509645302.89
Debt to equity: 0.55206732694078
Current ratio: 0.43867826787481384
Quick ratio: 0.43867826787481384
Interest coverage ratio: 1.7941078861780908
COGS to revenue (%): 33.18503276977459
SG&A to revenue (%): 4.0269083318179435
Free cash flow (dilution-adjusted): 76877000
Buyback yield (%): 0
Retained earnings: -1125390000
Receivables turnover: 3.64149873684115
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6581846171958183
FCF margin (%): 9.57522600059287
Revenue growth (%): 5.323958073698986
Rule of 40 score: 14.899184074291856
Financial ratios for CUZ — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 26.9
Shares outstanding: 164540333
Market cap (USD): 4426134957.7
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CUZ — annual report dated 2024-12-31
Total revenue: 856758000
Gross profit: 576097000
Operating income: 174486000
Net income: 46581000
Capital expenditures: 252731000
Operating cash flow: 400233000
Depreciation & amortization: 365045000
Net tangible assets: 4674689000
Owner earnings: 158895000
Return on net tangible assets (%): 3.3990496480086696
Capex to operating income (%): 144.84313927764978
Buffett classification: The Gruesome
Stock price: 28.27
P/E ratio: 99.8594966597969
Shares outstanding: 164540333
Book value: 4870167000
P/B ratio: 0.9551120554818756
Market cap (USD): 4651555213.91
Debt to equity: 0.6459057769476899
Current ratio: 0.38230521582925636
Quick ratio: 0.38230521582925636
Interest coverage ratio: 1.4246546262124824
COGS to revenue (%): 32.75849189619473
SG&A to revenue (%): 4.2679496427229155
Free cash flow (dilution-adjusted): 132714000
Buyback yield (%): 0.02388448484235269
Retained earnings: -1280547000
Receivables turnover: 3.5175165969396764
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.142031916503894
FCF margin (%): 15.490255124550922
Revenue growth (%): 6.711389333818257
Rule of 40 score: 22.20164445836918
Financial ratios for CUZ — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 28.27
Shares outstanding: 164540333
Market cap (USD): 4651555213.91
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CUZ — quarterly report dated 2025-03-31
Total revenue: 250328000
Gross profit: 173172000
Operating income: 60349000
Net income: 21093000
Capital expenditures: 54347000
Operating cash flow: 44758000
Depreciation & amortization: 102114000
Net tangible assets: 4648402000
Owner earnings: 68860000
Return on net tangible assets (%): 1.4813692963732483
Capex to operating income (%): 90.05451623059206
Buffett classification: The Gruesome
Stock price: 27.51
P/E ratio: 53.64936899480871
Shares outstanding: 164540333
Book value: 4837073000
P/B ratio: 0.9357941384862293
Market cap (USD): 4526504560.83
Debt to equity: 0.6348461145821037
Current ratio: 0.4149947100890137
Quick ratio: 0.4149947100890137
Interest coverage ratio: 1.6410779354979061
COGS to revenue (%): 30.821961586398643
SG&A to revenue (%): 4.2779872806877375
Free cash flow (dilution-adjusted): -15631000
Buyback yield (%): 0.006959012097896577
Retained earnings: -1314734000
Receivables turnover: 0.9796921535553408
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7510947683235623
FCF margin (%): -6.244207599629286
Rule of 40 score: -6.244207599629286
Financial ratios for CUZ — quarterly report dated 2025-06-30
Total revenue: 240128000
Gross profit: 165949000
Operating income: 55321000
Net income: 14658000
Capital expenditures: 71926000
Operating cash flow: 122554000
Depreciation & amortization: 100890000
Net tangible assets: 4618915000
Owner earnings: 43622000
Return on net tangible assets (%): 0.9444209300236095
Capex to operating income (%): 130.0157263968475
Buffett classification: The Gruesome
Stock price: 28.31
P/E ratio: 130.29388904450224
Shares outstanding: 164540333
Book value: 4801153000
P/B ratio: 0.9702121193034257
Market cap (USD): 4658136827.23
Debt to equity: 0.7345881291431454
Current ratio: 1.1339646802270058
Quick ratio: 1.1339646802270058
Interest coverage ratio: 1.436386768447837
COGS to revenue (%): 30.891441231343286
SG&A to revenue (%): 4.055337153518124
Free cash flow (dilution-adjusted): 46929000
Buyback yield (%): 0
Retained earnings: -1355394000
Receivables turnover: 0.9030118193886109
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6547046757755601
FCF margin (%): 19.543326892324096
Revenue growth (%): -4.074654053881307
Rule of 40 score: 15.468672838442789
Financial ratios for CUZ — quarterly report dated 2025-09-30
Total revenue: 248326000
Gross profit: 168303000
Operating income: 53521000
Net income: 8778000
Capital expenditures: 302032000
Operating cash flow: 120491000
Depreciation & amortization: 105272000
Net tangible assets: 4563054000
Owner earnings: -187982000
Return on net tangible assets (%): -4.1196531971789065
Capex to operating income (%): 564.3242839259356
Buffett classification: The Gruesome
Stock price: 27.58
P/E ratio: 101.91161679220282
Shares outstanding: 164540333
Book value: 4757663000
P/B ratio: 0.9538343476912929
Market cap (USD): 4538022384.139999
Debt to equity: 0.7061296691253668
Current ratio: 0.4359037373932196
Quick ratio: 0.4359037373932196
Interest coverage ratio: 1.2897558859676603
COGS to revenue (%): 32.22497845573963
SG&A to revenue (%): 3.8296432914797487
Free cash flow (dilution-adjusted): -184913000
Buyback yield (%): 0
Retained earnings: -1401660000
Receivables turnover: 0.9011325574897213
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6481444366280503
FCF margin (%): -74.46380966954729
Revenue growth (%): 3.414012526652452
Rule of 40 score: -71.04979714289483
Financial ratios for CUZ — annual report dated 2025-12-31
Total revenue: 993816000
Gross profit: 679318000
Operating income: 225317000
Net income: 41252000
Capital expenditures: 267231000
Operating cash flow: 402275000
Depreciation & amortization: 415359000
Net tangible assets: 4514852000
Owner earnings: 189380000
Return on net tangible assets (%): 4.1946003988613585
Capex to operating income (%): 118.60223596089065
Buffett classification: The Gruesome
Stock price: 24.84
P/E ratio: 99.07839308930475
Shares outstanding: 164540333
Book value: 4702202000
P/B ratio: 0.8692059319697453
Market cap (USD): 4087181871.72
Debt to equity: 0.7211514945551042
Current ratio: 0.5358122177697606
Quick ratio: 0.5358122177697606
Interest coverage ratio: 1.4149433876953799
COGS to revenue (%): 31.645495745691356
SG&A to revenue (%): 3.888244906501807
Free cash flow (dilution-adjusted): 118589000
Buyback yield (%): 0
Retained earnings: -1460154000
Receivables turnover: 3.4644635013595484
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.737977019740625
FCF margin (%): 11.932691765880204
Revenue growth (%): 15.997282779968206
Rule of 40 score: 27.92997454584841
Financial ratios for CUZ — quarterly report dated 2025-12-31
Total revenue: 255034000
Gross profit: 171894000
Operating income: 56126000
Net income: -3277000
Capital expenditures: 0
Operating cash flow: 114472000
Depreciation & amortization: 107083000
Net tangible assets: 4514852000
Owner earnings: 103806000
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 24.84
P/E ratio: 99.07839308930475
Shares outstanding: 164540333
Book value: 4702202000
P/B ratio: 0.8692059319697453
Market cap (USD): 4087181871.72
Debt to equity: 0.7211514945551042
Current ratio: 0.5358122177697606
Quick ratio: 0.5358122177697606
Interest coverage ratio: 1.3219804032410025
COGS to revenue (%): 32.599574958632964
SG&A to revenue (%): 3.4054282958350655
Free cash flow (dilution-adjusted): 272204000
Buyback yield (%): 0
Retained earnings: -1460154000
Receivables turnover: 0.889053893885519
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6820244287380105
FCF margin (%): 106.73243567524331
Revenue growth (%): 2.7012878232645794
Rule of 40 score: 109.43372349850789
Financial ratios for CXL.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.007518796992481
Shares outstanding: 215923560
Market cap (USD): 433470605.4135338
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CXL.AX — annual report dated 2022-06-30
Total revenue: 12736368.27586207
Gross profit: 3586004.1379310344
Operating income: -13082722.068965517
Net income: -11267753.793103449
Capital expenditures: 5130180
Depreciation & amortization: 2889339.310344828
Net tangible assets: 20959395.172413792
Owner earnings: -13508594.48275862
Return on net tangible assets (%): -64.4512609817018
Buffett classification: The Gruesome
Stock price: 4.220689655172414
Shares outstanding: 215923560
Book value: 33448904.827586208
P/B ratio: 27.24592451374935
Market cap (USD): 911346336.0000001
Debt to equity: 0.03339176384971895
Current ratio: 2.276255238054663
Quick ratio: 1.8680920541022368
Interest coverage ratio: -229.07520739998307
COGS to revenue (%): 71.84437462657843
R&D to revenue (%): 38.41869825502143
SG&A to revenue (%): 69.77059556954849
Free cash flow (dilution-adjusted): -8800300
Buyback yield (%): 0
Retained earnings: -36345858.62068965
Inventory turnover: 2.0247245385475114
Receivables turnover: 3.889937285758639
Capitalized R&D asset: 4893146.8965517245
ROCI (R&D-adjusted, %): -24.89889172789827
FCF margin (%): -69.09583493026268
Rule of 40 score: -69.09583493026268
Financial ratios for CXL.AX — annual report dated 2023-06-30
Total revenue: 12317631.78807947
Gross profit: 4103772.1854304634
Operating income: -22573996.68874172
Net income: -15354884.105960265
Capital expenditures: 6526564.238410596
Depreciation & amortization: 3881305.9602649007
Net tangible assets: 60274356.291390724
Owner earnings: -18000142.384105958
Return on net tangible assets (%): -29.863682487268644
Buffett classification: The Gruesome
Stock price: 2.76158940397351
Shares outstanding: 215923560
Book value: 69504060.92715232
P/B ratio: 8.579242815599168
Market cap (USD): 596292215.3642384
Debt to equity: 0.012624961491601635
Current ratio: 4.256211994479289
Quick ratio: 4.04918373866187
Interest coverage ratio: -104.24906873329378
COGS to revenue (%): 66.68375661787572
R&D to revenue (%): 78.12829979788837
SG&A to revenue (%): 106.94350057829125
Free cash flow (dilution-adjusted): -20058084.105960265
Buyback yield (%): 0
Retained earnings: -50256536.42384106
Inventory turnover: 2.861487996238493
Receivables turnover: 1.8042152169617507
Capitalized R&D asset: 12901964.712080384
ROCI (R&D-adjusted, %): -21.31027832579493
Rosenberg metric: 0.10581494045566218
FCF margin (%): -162.84042623657336
Revenue growth (%): -3.287722832074412
Rule of 40 score: -166.1281490686478
Financial ratios for CXL.AX — annual report dated 2024-06-30
Total revenue: 19634666.666666668
Gross profit: 10364666.666666666
Operating income: -25947333.333333332
Net income: -16842000
Capital expenditures: 10055333.333333334
Depreciation & amortization: 4942000
Net tangible assets: 45012000
Owner earnings: -21955333.333333336
Return on net tangible assets (%): -48.77662253028823
Buffett classification: The Gruesome
Stock price: 0.9466666666666667
Shares outstanding: 215923560
Book value: 56002666.66666667
P/B ratio: 3.6499625636874433
Market cap (USD): 204407636.8
Debt to equity: 0.03878386743488405
Current ratio: 2.0495703899537343
Quick ratio: 1.8383033319077795
Interest coverage ratio: -201.66321243523313
COGS to revenue (%): 47.21241341844357
R&D to revenue (%): 72.59269319570826
SG&A to revenue (%): 87.17574358277876
Free cash flow (dilution-adjusted): -22083333.333333332
Buyback yield (%): 0
Retained earnings: -67433333.33333333
Inventory turnover: 2.558888479941112
Receivables turnover: 7.5113491456261166
Capitalized R&D asset: 22315854.52442719
ROCI (R&D-adjusted, %): -26.572069883598026
Rosenberg metric: 0.6505801277265062
FCF margin (%): -112.47113948118972
Revenue growth (%): 59.40293560056197
Rule of 40 score: -53.068203880627756
Financial ratios for DFY.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 21.874015748031496
Shares outstanding: 120215798
Market cap (USD): 2629602258.6141734
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DFY.TO — annual report dated 2022-12-31
Total revenue: 2201617647.0588236
Net income: 81985294.11764705
Capital expenditures: 66764705.88235293
Operating cash flow: 224852941.17647058
Depreciation & amortization: 53676470.58823529
Net tangible assets: 1307500000
Owner earnings: 68897058.8235294
Return on net tangible assets (%): 5.2693735237881
Buffett classification: The Gruesome
Stock price: 27.044117647058822
P/E ratio: 39.655040811121076
Shares outstanding: 120215798
Book value: 1954632352.941177
P/B ratio: 1.663294981920776
Market cap (USD): 3251130184.1470585
Debt to equity: 0.026633562803295333
Effective tax rate (%): 2.0210896309314585
COGS to revenue (%): 0
SG&A to revenue (%): 0.5043083294369113
Free cash flow (dilution-adjusted): 142720588.2352941
Buyback yield (%): 1.2122481252230173
Retained earnings: 211617647.05882353
Receivables turnover: 7.80349231170185
Capitalized R&D asset: 0
FCF margin (%): 6.482532896934072
Rule of 40 score: 6.482532896934072
Financial ratios for DFY.TO — annual report dated 2023-12-31
Total revenue: 3056136363.6363635
Net income: 268560606.06060606
Capital expenditures: 66287878.78787878
Operating cash flow: 266515151.5151515
Depreciation & amortization: 80151515.15151514
Net tangible assets: 1225606060.6060605
Owner earnings: 282424242.4242424
Return on net tangible assets (%): 23.043639510446283
Buffett classification: The Gruesome
Stock price: 27.598484848484848
P/E ratio: 12.353911202087447
Shares outstanding: 120215798
Book value: 2277954545.4545455
P/B ratio: 1.4564706246100634
Market cap (USD): 3317773879.651515
Debt to equity: 0.049852007050450634
Effective tax rate (%): 24.122431506849313
COGS to revenue (%): 0
SG&A to revenue (%): 2.1838824025185293
Free cash flow (dilution-adjusted): 184696969.6969697
Buyback yield (%): 0.3173906182964189
Retained earnings: 425227272.7272727
Receivables turnover: 12.276628119293974
Capitalized R&D asset: 0
FCF margin (%): 6.04347933863811
Revenue growth (%): 38.81322071155749
Rule of 40 score: 44.8567000501956